{"nctId":"NCT03272685","briefTitle":"Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace","startDateStruct":{"date":"2018-06-01","type":"ACTUAL"},"conditions":["Tobacco Smoking","Nicotine Dependence"],"count":799,"armGroups":[{"label":"Very Low Nicotine Content Cigarettes","type":"EXPERIMENTAL","interventionNames":["Drug: Very Low Nicotine Content Cigarettes"]},{"label":"Normal Nicotine Content Cigarettes","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Normal Nicotine Content Cigarettes"]}],"interventions":[{"name":"Very Low Nicotine Content Cigarettes","otherNames":["Reduced Nicotine Content Cigarettes"]},{"name":"Normal Nicotine Content Cigarettes","otherNames":["Conventional Nicotine Content Cigarettes"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Male or female;\n2. 18/21 (legal age to purchase tobacco at site);\n3. Biochemically confirmed smoker.\n\nExclusion Criteria:\n\n1. Unstable health condition;\n2. Unstable medications;\n3. Pregnant or nursing.","healthyVolunteers":true,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Cigarettes Per Day (CPD)","description":"The mean cigarettes (study and non-study cigarettes) smoked per day based on 7 days Daily Interactive Voice Response (IVR) data at the end of Phase 3 (experimental marketplace with study cigarettes) compared to Phase 2 (experimental marketplace with usual brand cigarettes).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.05","spread":"7.88"},{"groupId":"OG001","value":"12.95","spread":"9.07"}]}]}]},{"type":"PRIMARY","title":"Number of Smoke-free Days","description":"Rate of smoke-free days, defined as no cigarettes smoked in the past 24 hours calculated as the proportion of smoke-free days out of the total number of days in Phase 3.\n\nNumber of smoke free days based on the interactive voice response (IVR)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.6","spread":"28"},{"groupId":"OG001","value":"5.1","spread":"13.8"}]}]}]},{"type":"SECONDARY","title":"Percent Change in 2-cyanoethyl-mercapturic Acid (CEMA)","description":"Change in CEMA (biomarker for the mercapturic acid acrylonitrile) from end of Phase 2 (experimental marketplace with usual brand cigarettes) to end of Phase 3 (experimental marketplace with study cigarettes).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-34","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Study Cigarettes Per Day","description":"The mean study cigarettes smoked per day based on 7 days Daily Interactive Voice Response (IVR) data at the end of Phase 3 (experimental marketplace with study cigarettes) compared to Phase 2 (experimental marketplace with usual brand cigarettes).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.33","spread":"6.86"},{"groupId":"OG001","value":"12.42","spread":"9.23"}]}]}]},{"type":"SECONDARY","title":"Seven Day Point-prevalence CO-verified Abstinence","description":"Total cigarettes per day equal to 0 for all 7 days before the week 12 visit and carbon monoxide (CO) â‰¤ 6ppm at week 12.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"41","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":7,"n":220},"commonTop":["Elevated CES-D score","Cough","Nasal congestion/Rhinorrhea","Headache/Migraine","Myalgia"]}}}